Equities

Eyenovia Inc

EYEN:NAQ

Eyenovia Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.7499
  • Today's Change-0.071 / -8.65%
  • Shares traded1.02m
  • 1 Year change-78.99%
  • Beta1.7104
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • EYEN:NAQ reported earnings of -0.23 for the period of the year 2024Q1.
  • EYEN:NAQ price moved over +8.92% to 0.90
  • EYEN:NAQ price falls below 50-day moving average to 0.85 at 10:30 BST
  • EYEN:NAQ trading volume exceeds daily average by +15.02%
  • EYEN:NAQ price rises above 50-day moving average to 0.99 at 10:33 BST
  • EYEN:NAQ price rises above 15-day moving average to 0.8422 at 10:33 BST
  • EYEN:NAQ price falls below 15-day moving average to 0.816 at 11:00 BST

Key statistics

On Friday, Eyenovia Inc (EYEN:NAQ) closed at 0.7499, 49.68% above the 52 week low of 0.501 set on Apr 10, 2024.
52-week range
Today
0.501Apr 10 20243.64May 17 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.8221
High0.8699
Low0.7498
Bid0.781
Offer0.81
Previous close0.8209
Average volume1.18m
Shares outstanding53.87m
Free float42.70m
P/E (TTM)--
Market cap40.40m USD
EPS (TTM)-0.6639
USD
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.